PainScript Achieves Early Patient Enrollment Milestone

Over 1,200 patients enrolled in the first quarter of commercial outreach  

New York, NY – March 17, 2022 – PainScript, Inc., a telehealth and compliance technologies  (TACT) company offering a flexible personalized digital telehealth platform for chronic care  management, and a subsidiary of Optimus Healthcare Services, Inc. (“Optimus”) (OTC: OHCS),  announced today that the first quarter (1Q 2022) of commercial patient enrollment has already  exceeded 1,200 patients among the initial healthcare practices utilizing PainScript’s Pain  Management and Substance Use Disorder (“SUD”) platform. All these patients were enrolled in  60-90 day “kick starter” programs, with the goal of converting the “kick starter” programs into  traditional enterprise usage relationships.  

“The initial launch of PainScript’s TACT platform, designed to improve health outcomes for pain  and SUD patients requiring on-going care plan management, has exceeded our expectations,” said  Dan Cohen, CEO of PainScript and President of Optimus. “With physician practices located from  Texas through New York, more than 1,200 patients have already been enrolled and are sending  daily clinical data to their physicians for evaluation and management of their health condition.”  

Mr. Cohen continued: “Just as important, our TACT platform has performed as expected for user  experience and acceptance, and the rollout has been smooth due to the reliability and performance of our TACT platform. As a consequence of being recently named the “Best Chronic Care  Management Platform” by GHP Magazine, we were able to augment our internal sales team by  recruiting an external affiliate sales force which has led to our robust sales funnel”. 

“We invested in and have faith in the PainScript TACT platform because it is an easy-to-use  mobile app which connects physicians with their patients in an individualized manner and is  designed to improve medication compliance and care plan adherence,” said Marc Wiener, Chief  Executive Officer of Optimus. “Validated through nine peer-reviewed and published trials,  PainScript is the lead entity in our TACT portfolio. As we make plans to expand our TACT  offerings, I look forward to both PainScript’s continued progression and the near-term launch of a bariatric vertical.” 

About PainScript, Inc. 

PainScript, a subsidiary of Optimus Healthcare Services, Inc. (OTC: OHCS), is a telehealth and  compliance technologies (TACT) company offering a personalized, flexible telehealth platform  for physicians and their patients who require improved care plan management and medication  adherence within different chronic care conditions. For more information on PainScript, please  visit our website at https://www.painscript.com/.  

About Optimus Healthcare Services, Inc. 

Optimus Healthcare Services, Inc. is focused on creating a network of innovative healthcare  companies that advance clinical research, disease management and improve physician/patient  interactions. Optimus accomplishes this by acquiring a controlling interest in a variety of  healthcare-related businesses and then enhances the attributes of its portfolio companies by  improving the operational, technological, managerial and financial capabilities of each  company. Optimus’s portfolio of companies includes, PainScript, a solution provider in its  Telehealth and Compliance Technology (TACT) division, Clinical Research Alliance, a research  services provider focused on bringing state-of-the-art clinical trial capabilities to community based physicians, hospitals and their patients, and VaccinationsRx, a boutique concierge 

vaccination pharmacy dedicated to simplifying access to vaccines. For more information on  Optimus, please visit our website at https://www.optimushealthcare.com/.  

Caution Concerning Forward Looking Statements: 

This press release may contain forward-looking statements made in reliance upon the safe harbor  provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the  Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements  that do not relate solely to historical or current facts and can be identified by the use of words such  as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,”  “should,” “continue” or the negative versions of those words or other comparable words. Forward 

looking statements are not a guarantee of future actions or performance. These forward-looking  statements are based on information currently available to Optimus Healthcare Services, Inc. and  its wholly owned subsidiary PainScript and its current plans or expectations and are subject to a  number of uncertainties and risks that could significantly affect current plans. Risks concerning  Optimus Healthcare’s business are described in Reports filed with the OTC Markets. Neither  Optimus Healthcare nor PainScript is under any obligation to (and expressly disclaims any such  obligation to) update or alter its forward-looking statements, whether as a result of new information,  future events or otherwise.